Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9000119rdf:typepubmed:Citationlld:pubmed
pubmed-article:9000119lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:9000119lifeskim:mentionsumls-concept:C0023467lld:lifeskim
pubmed-article:9000119lifeskim:mentionsumls-concept:C0368761lld:lifeskim
pubmed-article:9000119lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:9000119lifeskim:mentionsumls-concept:C0059438lld:lifeskim
pubmed-article:9000119pubmed:issue2lld:pubmed
pubmed-article:9000119pubmed:dateCreated1997-2-12lld:pubmed
pubmed-article:9000119pubmed:abstractTextInformation on the anti-carcinogenic effect of EGCG, the main constituent of the polyphenols present in Japanese green tea leaves, has recently been accumulating. In this report, we evaluate the effect of EGCG on leukemic blast cells from AML patients. The results showed that EGCG inhibited the proliferation of AML cells in all cases examined. Since AML cells might proliferate by autocrine or paracrine growth mechanisms, we also examined the effect of EGCG on the production of GM-CSF from AML cells. Although EGCG did not directly inhibit the production of GM-CSF, it did inhibit the effect of TNF-alpha or TPA, both of which stimulated AML cells to produce GM-CSF. On the other hand, the modulation of receptors for growth factors might play a role in the proliferation or carcinogenesis of AML cells. We also found that EGCG inhibited the modulation of c-kit, a receptor for stem cell factor, on leukemic cells. These findings suggested that EGCG might be available as a new therapeutic tool for AML patients.lld:pubmed
pubmed-article:9000119pubmed:languageenglld:pubmed
pubmed-article:9000119pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9000119pubmed:citationSubsetIMlld:pubmed
pubmed-article:9000119pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9000119pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9000119pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9000119pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9000119pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9000119pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9000119pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9000119pubmed:statusMEDLINElld:pubmed
pubmed-article:9000119pubmed:issn0024-3205lld:pubmed
pubmed-article:9000119pubmed:authorpubmed-author:BRUCEM AMAlld:pubmed
pubmed-article:9000119pubmed:authorpubmed-author:LaraF YFYlld:pubmed
pubmed-article:9000119pubmed:authorpubmed-author:EtoTTlld:pubmed
pubmed-article:9000119pubmed:authorpubmed-author:OtsukaTTlld:pubmed
pubmed-article:9000119pubmed:authorpubmed-author:OgoTTlld:pubmed
pubmed-article:9000119pubmed:authorpubmed-author:OkamuraSSlld:pubmed
pubmed-article:9000119pubmed:issnTypePrintlld:pubmed
pubmed-article:9000119pubmed:volume60lld:pubmed
pubmed-article:9000119pubmed:ownerNLMlld:pubmed
pubmed-article:9000119pubmed:authorsCompleteYlld:pubmed
pubmed-article:9000119pubmed:pagination135-42lld:pubmed
pubmed-article:9000119pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:9000119pubmed:meshHeadingpubmed-meshheading:9000119-...lld:pubmed
pubmed-article:9000119pubmed:meshHeadingpubmed-meshheading:9000119-...lld:pubmed
pubmed-article:9000119pubmed:meshHeadingpubmed-meshheading:9000119-...lld:pubmed
pubmed-article:9000119pubmed:meshHeadingpubmed-meshheading:9000119-...lld:pubmed
pubmed-article:9000119pubmed:meshHeadingpubmed-meshheading:9000119-...lld:pubmed
pubmed-article:9000119pubmed:meshHeadingpubmed-meshheading:9000119-...lld:pubmed
pubmed-article:9000119pubmed:meshHeadingpubmed-meshheading:9000119-...lld:pubmed
pubmed-article:9000119pubmed:meshHeadingpubmed-meshheading:9000119-...lld:pubmed
pubmed-article:9000119pubmed:meshHeadingpubmed-meshheading:9000119-...lld:pubmed
pubmed-article:9000119pubmed:meshHeadingpubmed-meshheading:9000119-...lld:pubmed
pubmed-article:9000119pubmed:meshHeadingpubmed-meshheading:9000119-...lld:pubmed
pubmed-article:9000119pubmed:meshHeadingpubmed-meshheading:9000119-...lld:pubmed
pubmed-article:9000119pubmed:year1997lld:pubmed
pubmed-article:9000119pubmed:articleTitleEffect of (-)-epigallocatechin gallate on leukemic blast cells from patients with acute myeloblastic leukemia.lld:pubmed
pubmed-article:9000119pubmed:affiliationFirst Department of Internal Medicine, Faculty of Medicine, Kyushu University, Fukuoka, Japan.lld:pubmed
pubmed-article:9000119pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:9000119pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9000119lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9000119lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9000119lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9000119lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9000119lld:pubmed